SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001104659-16-162150
Filing Date
2016-12-15
Accepted
2016-12-14 20:30:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 FWP a16-22195_3fwp.htm FWP 21431
2 GRAPHIC g221953bgi001.jpg GRAPHIC 4705
  Complete submission text file 0001104659-16-162150.txt   29524
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filed by) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: FWP
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-214197 | Film No.: 162052183
SIC: 2834 Pharmaceutical Preparations